Qube Research & Technologies LTD Immatics N.V. Transaction History

Qube Research & Technologies LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$9.78 - $13.49 $1.98 Million - $2.73 Million	-202,633 Reduced 90.1%	22,275 $258,000
Q1 2024 May 14, 2024	BUY	$10.23 - $12.94 $2.28 Million - $2.88 Million	222,460 Added 9087.42%	224,908 $2.36 Million
Q4 2023 Feb 13, 2024	BUY	$7.36 - $10.89 $18,017 - $26,658	2,448 New	2,448 $25,000

101

75.8M

238K

727K

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $541M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.